Coronavirus (COVID-19)

View Life Sciences by content type:

Latest Life Sciences News

Featured Life Sciences content

Practice notes
Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As
Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes
Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
Practice notes
Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As
Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes
Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents
Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
Practice notes
Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes
Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
Precedents
1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
Practice notes
Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents
Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
Practice notes
Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes
Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
Practice notes
SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes
ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent Coronavirus (COVID-19) content

Practice notes
Coronavirus (COVID-19)—UK life sciences trackerThis Practice Note tracks the developments and updates on coronavirus (COVID-19) that relate to the...
Read More >
20th Sep
Practice notes
Coronavirus (COVID-19) implications for dispute resolutionThis Practice Note aims to assist dispute resolution practitioners seeking to understand the...
Read More >
15th Sep
Q&As
Can I rely on ‘Certificates of Force Majeure’ issued by the Chinese government confirming that coronavirus (COVID-19) is force majeure as a force...
Read More >
Produced in partnership with Richard Colbey of Lamb Chambers 15th Sep
Q&As
Can my force majeure clause protect me against the economic impact of coronavirus (COVID-19)?Is there a force majeure event?In English law, the...
Read More >
15th Sep
Q&As
How do I activate a force majeure provision?There is no judicially accepted definition of the term ‘force majeure’, so what the parties mean by it...
Read More >
Produced in partnership with Richard Nicholas of Browne Jacobson 15th Sep
Q&As
Is a force majeure clause enforceable in a business-to-consumer contract because of coronavirus (COVID-19)?Traders seeking to rely on force majeure...
Read More >
13th Sep
Practice notes
Coronavirus (COVID-19)—EU life sciences trackerThis Practice Note tracks the developments and updates on coronavirus (COVID-19) that relate to the...
Read More >
6th Sep
Practice notes
Coronavirus (COVID-19)—regulatory implications for the UK and European life sciences industryCoronavirus (COVID-19) presents an unprecedented...
Read More >
Produced in partnership with Maria Isabel Manley of Sidley Austin, Zina Chatzidimitriadou of Sidley Austin and Sidley Austin 16th Aug
Q&As
Could the Brexit transition period be extended due to coronavirus (COVID-19)?Responding to the coronavirus (COVID-19) pandemic is impacting government...
Read More >
12th Aug
Q&As
My company needs to enter into a document as a deed but everyone is working from home. Is it possible to execute a deed by virtual means?Many...
Read More >
11th Aug
Practice notes
Coronavirus (COVID-19)—intellectual property implications for life sciences companiesIntroductionWe are facing a new life-threatening virus, rapidly...
Read More >
Produced in partnership with Chris Boyle, Bethany Wise and Maria Isabel Manley of Sidley Austin LLP 31st Jul
Q&As
If I can’t meet the people I am contracting with to sign a contract, how do I execute a contract by virtual means?Many businesses are closing their...
Read More >
31st Jul
Practice notes
Coronavirus (COVID-19) and intellectual property rightsThis Practice Note discusses some of the key considerations and implications for IP...
Read More >
31st Jul

Popular documents